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Abstract  The  global  presence  and  rapid  dissemination  of  Beijing  genotype  of
Mycobacterium  tuberculosis, makes  it  an  important  issue  of  public  health.  Its  pres-
ence  and  association  with  multi-drug  resistance  has  been  shown  in  many  settings.Spoligotyping;
Beijing;
MDR;
Drug  resistance
In  present  study  we  tried  to  ﬁnd  its  prevalence  and  association  with  drug  resis-
tance  in  North  India.  One  hundred  and  twenty  four  M.  tuberculosis  isolates  were
analyzed  with  spoligotyping,  further  drug  susceptibility  testing  was  done  by  1%  pro-
portional  method.  Out  of  these,  11  (8.9%)  M.  tuberculosis  isolates  were  identiﬁed
as  Beijing  and  113  (91.1%)  as  non-Beijing  genotypes.  While  looking  at  their  drugPlease  cite  this  article  in  press  as:  Mathuria  JP,  et  al.  Prevalence  of  Mycobacterium  tuberculosis  Bei-
jing  genotype  and  its  association  with  drug  resistance  in  North  India.  J  Infect  Public  Health  (2016),
http://dx.doi.org/10.1016/j.jiph.2016.06.007
susceptibility  patterns,  6  (54.5%)  &  22  (19.5%)  were  found  to  be  multi  drug  resistant
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(MDR)  among  Beijing  and  non-Beijing  isolates  respectively.  Our  study  concluded  that
the  Beijing  strains  were  not  so  common  in  north  India  and  these  strains  do  not  fully
associate  with  MDR.
vier  Limited  on  behalf  of  King  Saud  Bin  Abdulaziz  University
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Chemiluminescent  detection  system  (Amersham
Biosciences, Buckinghamshire,  United  Kingdom).
Proper  controls  (H37Rv,  M.  bovis  BCG  and  Nega-©  2016  Published  by  Else
for  Health  Sciences.
Introduction
Beijing  family  genotypes  of  M.  tuberculosis  (MTB)
were ﬁrst  recognized  in  1995  and  are  accounted  for
86% of  the  tuberculosis  isolates  from  Beijing,  China,
and a  high  proportion  of  isolates  from  Mongolia,
South Korea,  Hong  Kong,  Malaysia  and  Vietnam.
In other  regions  like  Finland  and  India,  the  pres-
ence of  Beijing  family  genotype  is  relatively  rare
[1].  The  M.  tuberculosis  belonging  to  Beijing  family
has increased  ability  to  spread,  cause  the  diseases
and  has  higher  association  with  drug  resistance  in
comparison  to  non-Beijing  MTB  isolates  [2].  In  pre-
vious studies  from  Germany,  Cuba,  Estonia,  Russia,
and South  Africa  it  was  documented  that  the  trans-
mission of  drug  resistance  have  association  with
Beijing  family  genotype  strains  [3].  Strain  W  which
is a  highly  drug  resistant  strain;  reported  from  the
United States  also  belongs  to  the  Beijing  family
[3].
Outbreaks  of  MDR  tuberculosis  due  to  Beijing
genotype have  been  reported  in  several  parts  of
the world  [4].  Researchers  are  concerned  that
the Beijing  genotype  may  have  a  predilection  for
developing  drug  resistance  and  may  be  spread-
ing worldwide,  perhaps  as  a  result  of  increased
virulence [3,5]. Thus,  a  better  understanding
of the  clinical  and  epidemiological  relevance
of M.  tuberculosis  Beijing/W  lineage  may  allow
the development  of  better  strategies  for  TB
control.
In the  present  study,  we  have  attempted  to
assess the  prevalence  of  M.  tuberculosis  Beijing
genotype and  its  drug  resistance  pattern  in  North
India.
Materials and methods
StrainsPlease  cite  this  article  in  press  as:  Mathuria  JP,  et  
jing  genotype  and  its  association  with  drug  resistanc
http://dx.doi.org/10.1016/j.jiph.2016.06.007
One  hundred  and  twenty  four  randomly  selected
M. tuberculosis  isolates  from  three  different  loca-
tions of  North  India  were  included,  among  these,  83
t
p
irom  eastern  Uttar  Pradesh  (SA-1),  26  from  Sawai
adhopur,  Rajasthan  (SA-2)  and  15  isolates  from
uxar, Bihar  (SA-3).  For  the  isolation  of  these  MTB
solates,  the  specimen  were  collected  during  Oct.
004-Dec.  2007  for  SA-1  and  for  SA-2  and  SA-3  the
uration  was  Oct.  2004  to  March,  2005.  The  speci-
ens were  processed  by  modiﬁed  Petroff’s  method
nd inoculated  on  Lowenstein  Jensen  (LJ)  media
n duplicate.  After  further  incubation  the  growth
as observed  and  the  MTB  isolates  were  charac-
erized  using  standard  methods  like;  niacin  test,
rowth on  PNB  containing  media  and  catalase  test
6]  at  Department  of  Microbiology,  Institute  of  Med-
cal Sciences,  Banaras  Hindu  University,  Varanasi,
ndia.
NA isolation
NA  was  isolated  as  previously  described  [7]. In this
ethod the  DNA  was  extracted  by  phenol  and  chlo-
oform.  After  extraction  the  DNA  was  precipitated
y 70%  ethanol  and  kept  in  TE  (Tris  EDTA  buffer,  pH
.0).
poligotyping
poligotyping  was  performed  on  genomic  DNA  to
etect the  Beijing  genotype  (1—34  spacers  absent)
y using  the  standard  method  [8]  with  the  help
f commercially  available  kit  (Isogen  Biosciences,
V, Maarsen,  The  Netherlands).  In  brief  the  DR
egion was  ampliﬁed  by  previously  described  sets
f primers.  After  ampliﬁcation  the  ampliﬁed  DNA
as hybridized  on  to  the  membrane  which  con-
ains the  corresponding  probe  for  each  spacer
1—43). The  hybridization  pattern  was  visualized
ith a chemiluminescence  system,  using  Enhancedal.  Prevalence  of  Mycobacterium  tuberculosis  Bei-
e  in  North  India.  J  Infect  Public  Health  (2016),
ive control)  were  used  with  each  experiment.  The
attern of  each  isolate  was  compared  with  the
nternational  spoligotyping  database  SpolDB4.0  [9].
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rug susceptibility test
rug  susceptibility  testing  of  the  M.  tuberculosis
solates was  performed  by  standard  1%  proportion
ethod on  LJ-medium  using  M.  tuberculosis  strain
37Rv as  sensitive  control  [10]. In  this  drug  sus-
eptibility  method  the  isolate  was  called  resistant
f 1%  or  more  proportion  of  colonies  were  growing
n drug  containing  media,  compared  to  drug  free
edium.
esults
poligotyping
f  124  M.  tuberculosis  isolates  for  which  spoligo-
yping was  carried  out,  the  majority  of  isolates
elonged to  shared  type  ST26;  22  (26.51%)  in  SA-
 [11];  2  (7.69%)  in  SA-2  and  2  (13.3%)  in  SA-3.  Out
f these,  11  isolates  belonged  to  Beijing  genotype.
mong these  11  isolates,  9  (10.8%)  were  from  SA-
 [11]  and  1  isolate  each  was  found  in  SA-2  (3.8%)
nd SA-3  (6.6%).  Amongst  11  isolates,  10  were  rep-
esented  by  ST1  and  1  by  ST1651  (Table  1).
rug susceptibility testPlease  cite  this  article  in  press  as:  Mathuria  JP,  et  
jing  genotype  and  its  association  with  drug  resistanc
http://dx.doi.org/10.1016/j.jiph.2016.06.007
ll  one  hundred  twenty  four  isolates  (one  hundred
hirteen non-Beijing  and  eleven  Beijing)  were  sub-
ected for  drug  susceptibility  testing.  Among  these,
a
r
i
Table  1  Spoligotype  family  and  subfamily  distribution  in  t
Family  SA-1  SA-
n  %  n 
CAS1  D  25  30.1  6  
CAS  —  —  1  
CAS2  2  2.4  —  
BEIJING  9  10.8  1  
T1  8  9.6  1  
T2-T3  1  1.2  —  
T3  2  2.4  —  
EAI3  IN  3  3.6  2  
EAI1  SOM  2  2.4  —  
EAI5  3  3.6  5  
EAI  5/3  —  —  1  
H1  2  2.4  —  
H3  1  1.2  —  
H4  4  4.8  —  
MANU1  1  1.2  1  
X3  —  —  1  
U  1  1.2  —  
Orphan  19  22.9  7  
Total 83  100  26   PRESS
3
 (54.5%)  Beijing  strains  of  M.  tuberculosis, were
DR whereas  in  non-Beijing  isolates;  22  (19.5%)
ere MDR.  Three  (27.3%)  and  85  (75.2%)  isolates
ere sensitive  to  all  drugs  in  case  of  Beijing  and
on-Beijing  strains  of  M.  tuberculosis  respectively.
esistance to  isoniazid  (n = 7,  63.6%)  was  much
igher in  Beijing  strains  than  non-Beijing  (n  = 26,
23.0%).  The  ﬁnding  of  isolates  which  were  resis-
ant to  any  drug  was  much  lower  (n  =  28,  24.2%)
n non-Beijing  than  in  Beijing  isolates  (n  =  8,  72.7%)
Table  2).
iscussion
ycobacterium  tuberculosis  Beijing  strains  are
revalent  in  many  parts  of  the  world  and  often  give
ise to  large  institutional  outbreaks.  To  the  best  of
ur knowledge  this  is  the  ﬁrst  initiative  to  assess
he prevalence  of  Beijing  genotype  of  tuberculo-
is and  its  association  with  drug  resistance  from
hree study  areas.  These  study  areas  are  the  part
f three  major  states  of  the  India.  In  the  earlier
tudies it was  well  documented  about  presence  of
eijing genotype  of  MTB.  The  highest  prevalence
as been  detected  in  Asia  and  Eurasia,  while  rel-al.  Prevalence  of  Mycobacterium  tuberculosis  Bei-
e  in  North  India.  J  Infect  Public  Health  (2016),
tively  low  prevalence  of  Beijing  strains  has  been
eported  from  Western  Europe  [12,13].
In present  study,  by  analysis  with  spoligotyp-
ng, we  found  the  prevalence  of  M.  tuberculosis
hree  study  areas  analyzed  with  SpolDB4.
2  SA-3
%  n %
23.1  2  13.3
3.8  —  —
—  —  —
3.8  1  6.7
3.8  1  6.7
—  —  —
—  1  6.7
7.7  —  —
—  —  —
19.2  —  —
3.8  1  6.7
—  —  —
—  —  —
—  —  —
3.8  1  6.7
3.8  —  —
—  —  —
26.9  8  53.3
100  15  100
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Table  2  Drug  resistance  proﬁle  of  M.  tuberculosis  isolates  belonging  to  Beijing  genotype  and  non-Beijing  genotype.
S.  no. Proﬁle  No.  of  isolates
(n  =  11)
No. of  isolates
(n  =  113)
n  %  N  %
1  Sensitive  to  all  drugs  3  27.3  85  75.2
2  Resistant  to  all  drugs  3  27.3  12  10.6
3  MDR  6  54.5  22  19.5
4  Any  drug  resistance  8  72.7  28  24.8
5  Resistant  to  Isoniazid  7  63.6  26  23.0
6  Resistant  to  Ethambutol  5  45.5  19  16.8
7  Resistant  to  Streptomycin  6  54.5  15  13.3
8  Resistant  to  Rifampicin 6  54.5 23 20.3
9  Resistant  to  Isoniazid  alone 0  0  2  1.8
10  Resistant  to  Ethambutol  alone  1  9.1  5  3.5
11  Resistant  to  Streptomycin  alone  0  0  1  0.8
12  Resistant  to  Rifampicin  alone  0  0  0  0
13  Resistant  to  HES  3  27.3  10  8.8
14  Resistant  to  HER  4  36.4  13  11.5
15  Resistant  to  ESR 3 27.3  8  7.0
16  Resistant  to  HSR 3  27.3  13  11.5
17  Resistant  to  HE 4 36.4  13  11.5
18  Resistant  to  HS 6 54.5  12  10.6
19  Resistant  to  ES 3 27.3  9  8.2
20  Resistant  to  ER 4 36.4  14  12.4
21  Resistant  to  SR 5 45.5 9 8.2
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tBeijing  strain  was  8.9%  (11/124),  which  is
comparable with  other  Indian  studies  [14—17].  Two
Indian studies  published  from  New  Delhi  (8%)  and
Bombay  (7.4%)  showed  similar  prevalence  of M.
tuberculosis  Beijing  strain  [14,15], whereas  two
other studies  from  same  places  have  reported  the
prevalence  to  be  slightly  lower,  i.e.  3.8%  and  3%
respectively [16,17].  Two  studies  from  South  Korea
and Hong  Kong  reported  the  prevalence  of  Beijing
strains to  be  77%  and  70%  respectively  [18,19]. Sim-
ilarly studies  from  Yangon,  Myanmar  and  Russia  also
reported a  high  prevalence  of  31.9%  and  42—68.1%
respectively [20,21]. Another  study  from  Malawi
showed that  4.3%  patients  have  Beijing  genotype
[22].  In  our  study  the  prevalence  of  Beijing  geno-
type  is  low,  so  we  can  say  that  the  Beijing  genotype
is not  a  dominant  genotype  in  North  India.
In our  study  we  also  analyzed  the  association  of
M. tuberculosis  Beijing  strain  with  drug  resistance.
The MDR  cases  were  found  in  6  (54.5%)  isolates
out of  11  M.  tuberculosis  Beijing  strains,  whereas
a study  from  Bombay  showed  only  12.5%  to  be  MDR
[15],  whereas  the  MDR  were  found  19.5%  in  cases  of
non-Beijing  MTB.  This  ﬁnding  suggests  that  the  Bei-
jing genotypes  are  associated  with  drug  resistancePlease  cite  this  article  in  press  as:  Mathuria  JP,  et  
jing  genotype  and  its  association  with  drug  resistanc
http://dx.doi.org/10.1016/j.jiph.2016.06.007
at signiﬁcantly  higher  percentage  than  non-Beijing
family in  this  study.  A  study  from  China  has  reported
a low  percentage  difference  of  MDR  cases  between
e
B
aeijing  family  (11.3%)  and  non-Beijing  family  (7.4%)
23]. In  our  study,  the  Beijing  family  has  higher
roportion in  INH  resistant  (63.6%)  in  comparison
o non-Beijing  (23.0%).  In  the  Chinese  study  the
NH resistance  was  found  quite  similar  to  our  study
n case  of  non-Beijing  isolates  (18.4%)  but  much
ower in  case  of  Beijing  isolates  (21.7%)  [23].  A
tudy from  Delhi  reported  that  out  of  nine  Bei-
ing isolates,  seven  were  resistant  to  EMB,  SM,
nd INH,  and  one  isolate  was  resistant  to  all  four
rugs tested  [14]. A  South  African  study  reported
hat among  the  patients  with  Beijing  strains,  50
15%) from  the  urban  setting  and  63  (23%)  from
he rural  setting  had  drug-resistant  tuberculosis
4]. Among  Beijing  strains;  in  our  study  resistance
o any  drug  was  found  in  72.7%,  while  a Korean
tudy reported  any  drug  resistance  and  MDR  were
9.6%  and  33.4%  respectively  [18]. While  compar-
ng with  this;  the  non-Beijing  genotype  had  very
ow percentage  (24.8%)  of  isolates  that  were  hav-
ng any  drug  resistance.  This  ﬁnding  also  indicates
hat the  rate  of  developing  drug  resistance  is  higher
n Beijing  genotype  rather  in  non-Beijing  genotype
f MTB.  Surprisingly  a  study  from  Madrid  reported
hat all  isolates  were  susceptible  to  anti-TB  drugs,al.  Prevalence  of  Mycobacterium  tuberculosis  Bei-
e  in  North  India.  J  Infect  Public  Health  (2016),
xcept  1  streptomycin-resistant  strain  among  the
eijing strains  [24].  This  ﬁnding  is  not  in  a concord-
nce with  our  study.
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revalence  of  Mycobacterium  tuberculosis  
onclusion
ince  this  study  was  focused  on  set  of  samples
hat were  probably  less  than  representative,  it
s difﬁcult  to  draw  any  concrete  conclusions  on
he relationship  between  Beijing  family  genotype
trains and  its  association  with  the  resistance  to
ll ﬁrst-line  antituberculosis  drugs.  But  by  this  ﬁnd-
ng we  can  conclude  that  the  Beijing  genotype  of  M
uberculosis  is  not  always  associated  with  MDR  but
t is much  higher  than  non-Beijing  MTB.
unding
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